Treatment of Guillain-Barré syndrome with corticosteroids: lack of benefit?
Hughes
Richard A C
RA
Department of Clinical Neurosciences, Guy's, King's and St Thomas' School of Medicine, SE1 1 UL, London, UK. richard.a.hughes@kcl.ac.uk
D005938:Glucocorticoids / Q000627:therapeutic use*; D020275:Guillain-Barre Syndrome / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D010919:Placebos; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012107:Research Design / Q000592:standards; D016896:Treatment Outcome
D005938:Glucocorticoids; D016756:Immunoglobulins, Intravenous; D010919:Placebos; D008775:Methylprednisolone